StockData
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. (XRTX) income statement

XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 0/30
$0.84−0.05 (-5.73%)

Close on Nov 20, 2026Market cap $91.95KP/E –Yield –

See a number that looks wrong?